Related Experiment Video
Updated: Oct 16, 2025

High-Throughput Capable Three-Dimensional Tissue Model for Quantification of Electroporation Thresholds
Published on: August 19, 2025
Atorvastatin Modulates the Efficacy of Electroporation and Calcium Electrochemotherapy
Wojciech Szlasa1, Aleksander Kiełbik2,3, Anna Szewczyk3,4
1Faculty of Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland.
Abstract:
Electroporation is influenced by the features of the targeted cell membranes, e.g., the cholesterol content and the surface tension of the membrane. The latter is eventually affected by the organization of actin fibers. Atorvastatin is a statin known to influence both the cholesterol content and the organization of actin. This work analyzes the effects of the latter on the efficacy of electroporation of cancer cells. In addition, herein, electroporation was combined with calcium chloride (CaEP) to assess as well the effects of the statin on the efficacy of electrochemotherapy. Cholesterol-rich cell lines MDA-MB231, DU 145, and A375 underwent (1) 48 h preincubation or (2) direct treatment with 50 nM atorvastatin. We studied the impact of the statin on cholesterol and actin fiber organization and analyzed the cells' membrane permeability. The viability of cells subjected to PEF (pulsed electric field) treatments and CaEP with 5 mM CaCl2 was examined. Finally, to assess the safety of the therapy, we analyzed the N-and E-cadherin localization using confocal laser microscopy. The results of our investigation revealed that depending on the cell line, atorvastatin preincubation decreases the total cholesterol in the steroidogenic cells and induces reorganization of actin nearby the cell membrane. Under low voltage PEFs, actin reorganization is responsible for the increase in the electroporation threshold. However, when subject to high voltage PEF, the lipid composition of the cell membrane becomes the regulatory factor. Namely, preincubation with atorvastatin reduces the cytotoxic effect of low voltage pulses and enhances the cytotoxicity and cellular changes induced by high voltage pulses. The study confirms that the surface tension regulates of membrane permeability under low voltage PEF treatment. Accordingly, to reduce the unfavorable effects of preincubation with atorvastatin, electroporation of steroidogenic cells should be performed at high voltage and combined with a calcium supply.
Insights
Atorvastatin affects cancer cell membranes, altering electroporation efficacy. High voltage electroporation with calcium chloride is recommended for atorvastatin-treated cells to enhance treatment effectiveness.
Area of Science:
- Biophysics
- Cell Biology
- Pharmacology
Background:
- Electroporation efficacy depends on cell membrane properties like cholesterol and surface tension.
- Actin fiber organization influences membrane surface tension.
- Atorvastatin, a statin, modifies both cholesterol levels and actin organization.
Purpose of the Study:
- To investigate the impact of atorvastatin on electroporation and electrochemotherapy in cancer cells.
- To analyze how atorvastatin affects cell membrane properties and permeability.
- To determine optimal conditions for electroporation in atorvastatin-treated cells.
Main Methods:
- Cancer cell lines (MDA-MB231, DU 145, A375) were treated with atorvastatin (preincubation or direct).
- Cholesterol content, actin organization, and membrane permeability were analyzed.
- Cell viability after pulsed electric field (PEF) and calcium-enhanced electroporation (CaEP) was assessed.
- N- and E-cadherin localization was examined using confocal microscopy.
Main Results:
- Atorvastatin preincubation altered cholesterol levels and actin organization in a cell-line-dependent manner.
- Actin reorganization increased the electroporation threshold under low voltage PEF.
- High voltage PEF efficacy was modulated by changes in lipid composition.
- Atorvastatin reduced low voltage PEF cytotoxicity but enhanced high voltage PEF cytotoxicity.
Conclusions:
- Membrane surface tension regulates permeability under low voltage PEF.
- High voltage electroporation combined with calcium chloride is suggested for atorvastatin-treated cells to overcome unfavorable effects and enhance efficacy.
Related Concept Videos
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Electroconvulsive Therapy

